Photo via Al Jazeera

WHO announces start of Ebola vaccine clinical trial in DR Congo

Read the original at Al Jazeera ↗
Cite

AFP. (2026, October 24). WHO announces start of Ebola vaccine clinical trial in DR Congo. Al Jazeera. https://www.aljazeera.com/news/2026/10/24/who-announces-start-of-ebola-vaccine-clinical-trial-in-dr-congo?traffic_source=rss

Dated from the outlet's own feed. Check the original for its byline.

Al Jazeera · collected 2026-10-24 · by AFP

Quick Summary

The World Health Organization announced the start of a clinical trial in Bunia, DRC, for an Ebola vaccine called Ervebo, which will test its effectiveness against the Bundibugyo strain of the virus. The trial involves a ring vaccination approach and includes two additional candidate vaccines: one from the University of Oxford and another from Moderna. Both vaccines are expected to enter the trial soon. This initiative aims to gather evidence on vaccine efficacy across various demographics, including pregnant women and children over 12 years old.
Written by AI on 2026-10-24, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

As of October 24, 2026, the World Health Organization (WHO) began a clinical trial for an Ebola vaccine called Ervebo in Bunia, Democratic Republic of Congo (DRC), at the epicenter of the ongoing outbreak. The trial aims to determine if Ervebo offers any protection against the Bundibugyo strain of the virus, which is causing the current epidemic. Dr. Tedros Adhanom Ghebreyesus, WHO's director-general, announced this development on X (formerly Twitter), stating it would help assess vaccine candidates for the Bundibugyo virus.

The DRC declared its 17th Ebola outbreak in May 2026, which has since become the country’s worst on record with over 9,700 cases and more than 4,600 deaths. The WHO declared a public health emergency of international concern due to this outbreak spreading across four African countries, marking its widest geographical spread ever in Africa.

This trial is crucial as it could provide insights into whether existing vaccines can offer cross-protection against different Ebola strains, potentially aiding control measures and saving lives during the ongoing crisis.

Written for “Ebola Vaccine Clinical Trial In DRC” on 2026-11-02, grounded in this article and the 1 other(s) covering the same event.

Story

📰 Ebola Vaccine Clinical Trial In DRC
Health · 2 article(s) covering the same event. See how they differ ↓

Compared with similar articles

This article reads unscored and hedges 13% of its claims. Each row says how that neighbour differs.
Times of India
Hedges 3 of 18 claims Outlet record 59/100
The Guardian
⚖️ Leans strongly left Hedges 3 of 47 claims Outlet record 66/100
“Article A discusses a third Ebola case in Kenya and US's role, while Article B reports on the start of an Ebola vaccine clinical trial in DR Congo.”
Deutsche Welle
Hedges 4 of 25 claims Outlet record 95/100
“Article A reports on Nigeria's first confirmed case of Ebola, while Article B discusses a WHO announcement about an Ebola vaccine clinical trial in DR Congo.”
Toronto Star
Hedges 1 of 2 claims Outlet record 64/100
“The articles describe different events: one is about a summit called by Africa CDC regarding Ebola in Nigeria, and the other is about WHO starting an Ebola vaccine trial in DR Congo.”
The Straits Times
Hedges 4 of 30 claims Outlet record 66/100
“The articles describe different events related to the Ebola outbreak but do not refer to the same specific incident.”
Toronto Star
Hedges 3 of 37 claims Outlet record 64/100
“The articles describe different aspects of the Ebola outbreak: one covers the spread and impact of the disease, while the other reports on a clinical trial for an Ebola vaccine.”
BBC News
Hedges 2 of 26 claims Outlet record 68/100
“The articles describe different events: one reports on a second Ebola death in Kenya, while the other announces an Ebola vaccine clinical trial in DR Congo.”
CBC News
Hedges 6 of 55 claims Outlet record 60/100
“The articles describe different aspects of the Ebola outbreak response in multiple countries, not a single specific incident.”
CBC News
Hedges 3 of 26 claims Outlet record 60/100
“Article A reports on the start of an Ebola vaccine clinical trial in DR Congo, while Article B discusses the overall progression and impact of the Ebola outbreak reaching 10,000 cases.”
The Hindu
Hedges 3 of 22 claims Outlet record 77/100
“The articles describe different aspects of the Ebola outbreak in Congo; one reports on the start of a clinical trial for an Ebola vaccine, while the other reports on the total number of cases reaching 10,000.”
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
15
sentences that state something as happening or true
Uncertain
13%
2 of 15 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
60/100
Al Jazeera's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
2
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-24 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Al Jazeera · 4647 article(s) · 2 correction(s) detected
Running correction rate · 2 correction(s)

Who wrote this

AFP
881 article(s) here · 1 carrying a prediction
🔮 Throughout the eight-month war Mr. Trump has pursued dual tracks with Tehran: a campaign of airstrikes and other attacks, while seeking to reach a deal that would jumpstart peace talks and fully open the Strait of Hormuz to vital oil and gas traffic.
🔮 Ms. Iotova is projected to receive between 50.7% and 52.5% of the vote, compared to between 43.4% and 44% for Mr. Gyurov, according to three different exit polls.
2026-11-01 · assertive framing · Bulgarian President wins runoff election: exit polls
🔮 The head of Israel’s Central Elections Committee said on Sunday (November 1, 2026) that an ongoing investigation into alleged foreign funding in the country’s recent vote would not call into question its result, noting that so far “suspicions remain suspicions”.
🔮 Iran warned on Sunday (November 1, 2026) that any renewed war with the United States could last longer than the previous round of fighting, after President Donald Trump said he still had to "take care" of more targets.
🔮 "Within this year we will enable units to select and use all those types according to operational aims and specific features of targets," said the general director of the North's Missile Administration.
🔮 Iran warned on Sunday that any renewed war with the United States could last longer than the previous round of fighting, after President Donald Trump said he still had to “take care” of more targets.
🔮 “Beyond the medals, records and sporting accolades, Ciara will be remembered for her warmth, courage and tremendous strength of character,” said Northern Ireland’s First Minister Michelle O’Neill.
🔮 MotoGP said talks with the organisers in Qatar and safety advisers had not flagged any reasons to change plans for the event, which will run from Friday to November 8 at the Lusail International Circuit outside Qatar’s capital, Doha.
🔮 The head of a student group said a campaign of high school blockades would restart on Monday (November 2, 2026), adding the government's proposals did not go far enough.
🔮 “Within this year we will enable units to select and use all those types according to operational aims and specific features of targets,” said the general director of the North’s Missile Administration.
2026-11-01 · assertive framing · North Korea tests cluster-bomb warheads: KCNA
Wire or desk byline, not an individual reporter.
Also by AFP
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 881 articles by AFP →

Topics

DRC Ervebo The World Health Organization WHO the Democratic Republic of Congo

Subjects

WHO ORG · 6× DRC GPE · 4× 3Kenya GPE · 1× 3Nigeria GPE · 1× Bunia GPE · 1× DR Congo GPE · 1× Ituri GPE · 1× Tedros Adhanom Ghebreyesus PERSON · 1× The World Health Organization ORG · 1× the Democratic Republic of Congo GPE · 1×

Narrative

Recommended Stories list of 3 items- list 1 of 3Kenya announces second Ebola death, says ‘no evidence’ of community spread - list 2 of 3Nigeria’s first Ebola case matches DR Congo strain, health officials say - list 3 of 3WHO warns ‘more complex’ Ebola outbreak now present in 3 African countries Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will be put through a full-scale human trial to see
framing: assertive · carried by 1 article(s) · first seen 2026-10-24
🔮 Recommended Stories list of 3 items- list 1 of 3Kenya announces second Ebola death, says ‘no evidence’ of community spread - list 2 of 3Nigeria’s first Ebola case matches DR Congo strain, health officials say - list 3 of 3WHO warns ‘more complex’ Ebola outbreak now present in 3 African countries Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will be put through a full-scale human trial to see
2026-10-24 · Al Jazeera
WHO announces start of Ebola vaccine clinical trial in DR Congo · assertive framing

Claims (15 extracted, 2 hedged)

The World Health Organization (WHO) has announced the beginning of the first clinical trial of an Ebola vaccine in the outbreak that started in the Democratic Republic of Congo (DRC). asserted
that → announce → Congo
WHO’s director-general, Tedros Adhanom Ghebreyesus, said in a social media post on Friday that participants in the trial were vaccinated with the Ervebo vaccine in Bunia, the capital of the DRC’s northeastern Ituri province, which is the epicentre of the Ebola outbreak. asserted
which → say → outbreak
Recommended Stories list of 3 items- list 1 of 3Kenya announces second Ebola death, says ‘no evidence’ of community spread - list 2 of 3Nigeria’s first Ebola case matches DR Congo strain, health officials say - list 3 of 3WHO warns ‘more complex’ Ebola outbreak now present in 3 African countries Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will be put through a full-scale human trial to see asserted
Ervebo → announce → trial
if it offers any cross-protection against the Bundibugyo species of Ebola that is behind the epidemic. asserted
that → offer → epidemic
“This trial will help us understand whether any of the vaccine candidates designed for Bundibugyo virus work,” the WHO chief said on X. “WHO is supporting this DRC-led effort to find answers and save lives,” he added. asserted
he → help → lives
The DRC declared its 17th and worst-ever Ebola outbreak in May and has since reported more than 9,700 cases, with the number of deaths exceeding 4,600. uncertain
number → declare → 4,600
The WHO, in response, triggered a public health emergency of international concern, its second-highest alert level. asserted
WHO → trigger → concern
The current outbreak has now been reported in four countries across eastern, central and western Africa, giving it the widest geographic spread of any Ebola outbreak on the continent to date. asserted
outbreak → report → date
The so-called Tumaini trial is a single trial framework that can test the safety, efficacy and immunogenicity of multiple vaccines. asserted
that → call → vaccines
The trial will use a ring vaccination approach: immunising contacts deemed to be at high risk of infection. asserted
trial → use → infection
The trial is set to incorporate two Bundibugyo-specific candidate vaccines, which are currently advancing through earlier-stage, smaller-scale clinical trials. asserted
which → set → trials
One is a ChAdOx1 adenoviral vector jab being developed by the University of Oxford; the other, by the US-based Moderna group, uses mRNA technology. asserted
other → develop → technology
Both have received funding from the Coalition for Epidemic Preparedness Innovations and are expected to enter the trial “shortly”, CEPI said in a statement. asserted
CEPI → receive → statement
The trial will include pregnant women and children aged 12 years and older, generating evidence for populations that are often excluded from clinical trials. asserted
that → include → trials
WHO emergencies director Chikwe Ihekweazu said the trial was set up to generate the rigorous evidence needed to determine whether the participating vaccines could protect people at risk. uncertain
vaccines → say → risk
💬Give feedback
🕘History 🎫Support